Describe effect of genetic variation on the pharmacokinetics

Reference no: EM13745656

Question 1: Initial observations suggesting the presence of polymorphic CYP-mediated oxidative metabolism were based on inter-individual differences in an observed characteristic (e.g. drug concentration or clearance). Many early studies to characterize inter-individual variability in drug metabolism involved large population studies in which subjects were classified on the basis of function (i.e., enzyme activity) as being "poor metabolizers (PM)," "intermediate metabolizers (IM)," "extensive metabolizers (EM)," and in some cases "ultrarapid metabolizers (UM)."

Briefly define each of these terms with respect to genotype and phenotype. Specify a CYP enzyme that exhibits these phenotypic traits. Draw a figure to illustrate the expected genotype-phenotype relationship.

Question 2: In vitro data suggest that carboxylesterase 1 (CES1) metabolizes sofosbuvir, an ester pro-drug used for the treatment of hepatitis C infection. Describe your prediction for how a genetic polymorphism in CES1 would impact the bioavailability of sofosbuvir.

Question 3: The discovery of theorphan nuclear receptor pregnane X receptor (PXR),also referred to as the steroid and xenobiotic receptor, providedinsights into the molecular basis of how specific drugs couldinduce pathways of clearance and enhance rate of elimination of drugs. Genetic variation has been identified in PXR and the figure below shows data from a study designed to evaluate the functional significance of the variant.

Figure. Hepatic mRNA expression of PXR

Question:Based on these data, list twodrug metabolizing enzymes that could be affected by this genetic variation. List the enzymes and predict how enzyme activity would be affected. Describe the mechanism by which this polymorphism could impact enzyme activity.

Question 4: Bicalutamide is an oral non-steroidal anti-androgen used in the treatment of prostate cancer.

A. Identify in humans an intestinal transporter that limits bicalutamideabsorption.

B. Briefly describe the pharmacogenetics of this transporter. List two common alleles, the allele frequencies, and include a comment for each SNP on whether it is functionally relevant (i.e., alters transport). Only discuss SNPs for which the frequency is >5%.

C. Describe the effect of the genetic variation on the pharmacokinetics of bicalutamide.

Reference no: EM13745656

Questions Cloud

What event and figure have shaped development of islam in us : What events and figures have shaped the development of Islam in the United States?

Learn more about the chemist and increase drugs awareness : Describe an activity which would help your employee learn more about the Chemist and increase their drugs awareness

Analyzing events in the long run : According to the theory of purchasing power parity (PPP), what will happen to the value of the dollar (against foreign currencies) if the U.S. price level doubles and price levels in other countries remain constant? Why is the theory more suitable..

Did society develop or progress as a ideas : Did society develop or progress (either in a good or a bad way) as a result of pursuing any of these ideas? Can you see any similarities to other philosophies, such as those of Confucius or Buddha?

Describe effect of genetic variation on the pharmacokinetics : Bicalutamide is an oral non-steroidal anti-androgen used in the treatment of prostate cancer. Describe the effect of the genetic variation on the pharmacokinetics of bicalutamide

Why do most economists dislike these laws : Many states have usury laws, which place a ceiling on interest rates. Why do most economists dislike these laws?

Determining the current or future position : Discuss how you plan on using what you learned in this course in your current or future position. What will prove to be the most valuable?

Pricing strategy for a perfectly competitive firm : Industries are economies of scale exhausted at relatively low levels of output - The most important pricing strategy for a perfectly competitive firm

Bcr-abl1 monitoring test : Reaction set up- BCR/ABLtranscripts: You will assemble a ‘master mix' with sufficient volume to perform 2 x 20μL (repeat) reactions for each transcript level quantification. Remember to change pipette tips after pipetting each solution (to avoid c..

User Account

All Pages